Succinylcholine or Rocuronium for Rigid Bronchoscopy Under General Anesthesia
Information source: Hopital Foch
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Anesthesia
Intervention: succinylcholine (Drug); rocuronium (Drug)
Phase: Phase 4
Sponsored by: Hopital Foch
Official(s) and/or principal investigator(s):
Morgan Le Guen, MD, Principal Investigator, Affiliation: Hopital Foch
Myorelaxation is generally used as a part of general anesthesia for interventional rigid
bronchoscopy. Succinylcholine is most often used because its short duration of action but
rocuronium can be used since sugammadex permits a rapid and complete reversal of the
neuromuscular block. The aim of ths study is to compare both agents.
Official title: Interventional Rigid Bronchoscopy Under General Anesthesia: Influence of the Muscle Relaxant, Succinylcholine or Rocuronium, on the Quality of the Surgical Procedure
Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Caregiver), Primary Purpose: Treatment
Primary outcome: Score of quality of the surgical procedure
Secondary outcome: Score of quality of anesthesia
Minimum age: 18 Years.
Maximum age: N/A.
- patients scheduled for an interventional rigid bronchoscopy under general anesthesia
- pregnant woman or woman of childbearing age,
- morbid obesity,
- drug allergy,contra-indication to succinylcholine, rocuronium, sugammadex, propofol,
- history of central neurological or brain damage,
- psychotropic treatment,
- renal failure,
- disease of the neuromuscular junction.
Locations and Contacts
Hopital Foch, Suresnes, Ile de France 92151, France
Starting date: January 2012
Last updated: June 17, 2015